SF3B1 K700E rewires splicing of cell cycle regulators
RNA · 2026
DOI: 10.1261/rna.080661.125 ↗Kurz gefasst
Fachartikel in der Zeitschrift RNA, 2026. Verfasst von Mai Baker und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Biology, The Institute for Medical Research Israel-Canada, Faculty of Medicine, The Hebrew University of Jer…. Hauptthemen laut MEDLINE: RNA Splicing Factors, Phosphoproteins, Alternative Splicing, RNA Splicing. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Pre-mRNA splicing plays a crucial role in maintaining cellular homeostasis, with strict regulation required for processes such as cell cycle progression. SF3B1, a core component of the spliceosome, has emerged as a key player in alternative splicing regulation and is frequently mutated in cancer. Among these mutations, SF3B1 K700E disrupts normal splicing patterns and deregulates cell cycle control. Here we profiled K562 erythroleukemia cells expressing either wild type or SF3B1 K700E by RNA-seq and uncovered 763 high-confidence splicing alterations enriched for G 2 /M regulators, including ARPP19, ENSA, STAG2, and ECT2. Notably, increased inclusion of ARPP19 exon 2 produces the ARPP19-long isoform, which sustains PP2A-B55 inhibition and promotes mitotic progression. A core subset of the K700E-linked splicing changes reappeared after siRNA-mediated SF3B1 depletion in HeLa cells, underscoring a mutation-dependent spliceosomal signature that transcends cell type. Pharmacological inhibition of DYRK1A or broad serine/threonine phosphatases shifted ARPP19 exon 2 inclusion in the same direction as SF3B1 K700E , pointing to a kinase–phosphatase signaling axis that influences these splice events. Functionally, ectopic expression of ARPP19-long accelerated mitotic exit, and high ARPP19-long abundance is associated with poorer overall survival in the TCGA–AML cohort. Our findings highlight a connection between SF3B1-dependent splicing, cell cycle progression, and tumorigenesis, offering new insights into the molecular mechanisms underlying cancer-associated splicing dysregulation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry and Molecular Biology, The Institute for Medical Research Israel-Canada, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem 9112102, Israel mib.sal89@gmail.com maayan.salton@ma…
- Department of Biochemistry and Molecular Biology, Faculty of Medicine, Al-Quds University, East Jerusalem P144, Palestine.
- Department of Biochemistry and Molecular Biology, The Institute for Medical Research Israel-Canada, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem 9112102, Israel.
- Department of Military Medicine and "Tzameret," Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem 9112102, Israel.
- Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot 761001, Israel.
- Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA.
ORCID-Profile: Maayan Salton
Zitieren
APA
Baker, M., Engal, E., Sharma, A., Petasny, M., Jaffe-Herman, S., Geminder, O., Su, M., Bentata, M., Gershon, A., Kay, G., & Salton, M. (2026). SF3B1 K700E rewires splicing of cell cycle regulators. RNA. https://doi.org/10.1261/rna.080661.125
Vancouver
Baker M, Engal E, Sharma A, Petasny M, Jaffe-Herman S, Geminder O, et al. SF3B1 K700E rewires splicing of cell cycle regulators. RNA. 2026. doi:10.1261/rna.080661.125
BibTeX
@article{Baker2026,
author = {Baker, Mai and Engal, Eden and Sharma, Aveksha and Petasny, Mayra and Jaffe-Herman, Shiri and Geminder, Ophir and Su, Minhua and Bentata, Mercedes and Gershon, Adi and Kay, Gillian and Salton, Maayan},
title = {SF3B1 K700E rewires splicing of cell cycle regulators},
journal = {RNA},
year = {2026},
doi = {10.1261/rna.080661.125}
}
EUVIMED